Jefferies Group's PCRX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 370,092 shares of Pacira BioSciences, Inc. (PCRX) worth $9.39 M, representing 0.06% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in PCRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 173,800 shares. Largest reduction occurred in Q2 2025, reducing 130,700 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Pacira BioSciences (PCRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pacira BioSciences (PCRX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +173,800 | Add 88.54% | 370,092 | $25.37 |
| Q1 2026 | +24,200 | Add 14.06% | 196,292 | $22.60 |
| Q4 2025 | +123,805 | Add 256.39% | 172,092 | $25.88 |
| Q3 2025 | +4,695 | Add 10.77% | 48,287 | $25.77 |
| Q2 2025 | -130,700 | Reduce 74.99% | 43,592 | $23.90 |
| Q1 2025 | +75,522 | Add 76.46% | 174,292 | $24.85 |
| Q4 2024 | +70,220 | Add 245.95% | 98,770 | $18.84 |
| Q3 2024 | -21,550 | Reduce 43.01% | 28,550 | $15.05 |
| Q2 2024 | -2,621 | Reduce 4.97% | 50,100 | $28.61 |
| Q1 2024 | -10,640 | Reduce 16.79% | 52,721 | $29.22 |
| Q4 2023 | +28,699 | Add 82.80% | 63,361 | $33.74 |
| Q3 2023 | +20,351 | Add 142.21% | 34,662 | $30.68 |
| Q2 2023 | -13,815 | Reduce 49.12% | 14,311 | $40.07 |
| Q1 2023 | +451 | Add 1.63% | 28,126 | $40.81 |
| Q4 2022 | +27,675 | New Buy | 27,675 | $38.61 |
Jefferies Group's Pacira BioSciences Investment FAQs
Jefferies Group first purchased Pacira BioSciences, Inc. (PCRX) in Q4 2022, acquiring 27,675 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Pacira BioSciences, Inc. (PCRX) for 15 quarters since Q4 2022.
Jefferies Group's largest addition to Pacira BioSciences, Inc. (PCRX) was in Q2 2026, adding 370,092 shares worth $9.39 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 370,092 shares of Pacira BioSciences, Inc. (PCRX), valued at approximately $9.39 M.
As of the Q2 2026 filing, Pacira BioSciences, Inc. (PCRX) represents approximately 0.06% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Pacira BioSciences, Inc. (PCRX) was 370,092 shares, as reported at the end of Q2 2026.